Blood Coagulation Disorders D001778

Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Blood Coagulation Disorders

Description

Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.   MeSH

Subtype Terms (10)

Blood Coagulation Disorders, Inherited
1 experimental drug

Coagulation Protein Disorders
3 drugs (1 approved, 2 experimental)

Disseminated Intravascular Coagulation
10 drugs (7 approved, 3 experimental)

Ecchymosis
8 drugs (5 approved, 3 experimental)

Platelet Storage Pool Deficiency
6 approved drugs

Protein S Deficiency
 

Purpura
52 drugs (35 approved, 17 experimental)

Thrombocythemia, Essential
65 drugs (41 approved, 24 experimental)

Thromboinflammation
 

Vitamin K Deficiency
4 drugs (2 approved, 2 experimental)


Phase 1 Indicated Drugs (2)


Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.